RE:RE:RE:RE:RE:They say-----Good things come u's to---Picked up a few thousand as well. Two treatments, excellent safety profile, equal or better than Keytruda, base formulation can be potentially used across many indications, have FDA in closed loop for potential AA/BTD. And who knows, maybe they get authorization for early pre-BCG treatment either standalone or in conjunction with another drug. Everything says buy but why why why is this stuck in low gear? Unpredictability of the FDA response? Uncertainty or lack of confidence in the ability of a tiny company to get things right? No PR? Tiny Canadian exchange which is subject to manipulation and only monitored by us fools on this message board? Smart money knows more than we pretend to know? Combination of all of the above? We need something to go right here. Right?